Bevacizumab improves tumor infiltration of mature dendritic cells and effector T-cells in triple-negative breast cancer patients
Yves Boucher(Harvard University), Rakesh K. Jain(Harvard University)
Cited by 41
Related Papers
Anti-VEGF therapy improves EGFR-vIII-CAR-T cell delivery and efficacy in syngeneic glioblastoma models in mice
|Journal for ImmunoTherapy of Cancer|2023|113